Clinical Trials in Pittsburgh

Showing 241-260 of 16,007 trials

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

NCT00280189

The purpose of this study is to assess short and long term outcomes after radiofrequency ablation (RFA) of pulmonary malignancies in patients who are not candidates for surgical resection. This study will evaluate the efficacy of RFA for the treatment of lung tumors by assessing its impact on local tumor control, progression free survival, overall survival, dyspnea score and quality of life (QOL).

NSCLCPulmonary Metastases

University of Pittsburgh72 participantsStarted Sep 2003

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

NCT03626688

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.

PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more

United Therapeutics687 participantsStarted Aug 2018

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +206 more locations

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Find Trials by Condition in Pittsburgh

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

SIMPLAAFY Clinical Trial

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

Clinical Decision Support Tool in PARDS Pilot Study

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

A Study of ZW251 in Participants With Advanced Solid Tumors

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Retinoblastoma Phase II Expanded Access Clinical Trial